FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Control

(MedPage Today) -- A group of FDA advisors recommended approval of tenapanor (Ibsrela) for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on dialysis, both as a single agent and in combination with phosphate...